Are peptides legal in Arkansas?

Can a Arkansas resident get peptides by telehealth?

The Arkansas Telemedicine Act (Ark. Code 17-80-401 through 17-80-407, amended by Acts 767, 829, and 1112 of 2021) defines telemedicine to include store-and-forward technology and remote patient monitoring, and section 17-80-403 bars a distant-site professional from using telemedicine with an Arkansas patient unless a professional relationship exists. Section 17-80-402(4) lists the ways that relationship can exist: a prior in-person exam, personal knowledge through an ongoing relationship, treatment in consultation with or on referral from a professional who has a relationship with the patient, an on-call or cross-coverage arrangement, circumstances defined by Arkansas State Medical Board rule, or, added in 2021, an Arkansas-licensed professional who has access to the patient's health record and uses any technology the professional deems appropriate, including the telephone, to diagnose, treat, and if clinically appropriate prescribe a noncontrolled drug. The same subdivision says a health record may be created with the use of telemedicine if the professional meets the in-person standard of care, and the Medical Board's rule (17 CAR 140-202(b)(8)) mirrors this, so the 2021 amendments did broaden relationship formation: a telephone or video evaluation that builds a proper health record can support a first non-controlled prescription. Section 17-80-403(c) still excludes a relationship established only by an internet questionnaire, email, patient-generated medical history, text messaging, fax, or any combination of them, and the Medical Board's telemedicine rule (17 CAR 140-3201) adds that a patient completing a medical history online and forwarding it is not sufficient and does not count as store-and-forward, so a first GLP-1 or compounded peptide prescription cannot lawfully follow a questionnaire-only asynchronous intake. Once the relationship exists, follow-up care may use asynchronous tools if the standard of care is met. Section 17-80-404 and 17 CAR 140-3201 require the treating professional to be licensed in Arkansas. [2] [3] [4] [8] [9]

How does the Arkansas pharmacy board treat compounding?

The Arkansas State Board of Pharmacy regulates compounding under the Pharmacy Practice Act (Ark. Code Title 17, Chapter 92) and its compounding rule, now codified in the Code of Arkansas Rules as 17 CAR 160-2201 (Standards for compounding and dispensing compounded products, as amended effective June 29, 2026). That rule requires compounding pharmacies to comply with section 503A of the federal Food, Drug, and Cosmetic Act and the USP chapters on compounding numbered below 1000, generally prohibits compounding a drug that is commercially available or essentially a copy of an FDA approved product unless the prescriber documents a patient-specific medical need or the product is documented as unavailable, and requires a pharmacist in charge who oversees sterile compounding to keep written sterile procedures and certify Board-approved sterile training for pharmacists and technicians. Arkansas has no state bulks list, so peptide eligibility follows the federal 503A framework (approved drug component, USP or NF monograph, or FDA 503A bulks list). Arkansas is unusual in its nonresident rule: Ark. Code 17-92-401 requires any pharmacy outside the state that routinely ships dispensed legend drugs into Arkansas to hold an Arkansas pharmacy license, follow Arkansas law for the Arkansas part of its operation, keep an Arkansas-licensed pharmacist on staff as pharmacist in charge, and register an Arkansas agent for service of process. [1] [5] [6] [7] [12]

Can you get compounded GLP-1s in Arkansas?

Compounded semaglutide and tirzepatide are limited to documented patient-specific needs after the FDA shortage allowances ended in 2025, and Arkansas's own compounding regulation separately bars routine copies of commercially available drugs. Because Arkansas law does not let an online questionnaire alone establish the patient relationship, Arkansas patients should expect a live evaluation (in person, by video, or by telephone backed by a health record) before a first GLP-1 prescription, and should confirm the dispensing pharmacy holds an Arkansas license with an Arkansas-licensed pharmacist in charge. [3] [5] [7] [15]

Prices by channel: semaglutide cost, tirzepatide cost.

Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.

What is the legal access path in Arkansas?

Find a provider in Arkansas

• Compounding pharmacies in Arkansas
• Clinics in Arkansas
• Telehealth providers in Arkansas

Is it legal to buy research peptides in Arkansas?

Only Arkansas-licensed pharmacies may dispense prescription drugs to Arkansas patients, including out-of-state pharmacies licensed under Ark. Code 17-92-401. "Research use only" peptides sold for human injection are unapproved new drugs under federal law regardless of labeling, are not dispensed by a pharmacist, and carry no Arkansas licensing protections. The Arkansas Food, Drug, and Cosmetic Act (Ark. Code 20-56-201 and following) has no separate new-drug approval section, so the unapproved-drug prohibition comes from federal law; the state act does prohibit selling a misbranded drug (Ark. Code 20-56-215) and treats a drug as misbranded unless its labeling bears adequate directions for use and adequate warnings (Ark. Code 20-56-211). [5] [10] [11] [16]

Peptide-specific notes for Arkansas

Compare: Semaglutide vs tirzepatide.

Frequently asked questions

From the blog

• Can you get a GLP-1 through telehealth in your state?

  Yes in every state, but the rules for the visit, the prescriber's license, and the pharmacy differ. How state telehealth law shapes GLP-1 access, with ten state examples.

Sources

Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, and federal FDA guidance.